Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC

Clinical trial NCT05265650 · UNKNOWN

Trial details

NCT number: NCT05265650
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Metastatic

Start date: 2022-06-13
Primary completion: 2024-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.